Effects of Epinephrine and Intravenous (I.V.) Needle on Cardiopulmonary Resuscitation (CPR) Outcome

This study has been completed.
Sponsor:
Collaborators:
Laerdal Medical
Ullevaal University Hospital
Health Region East, Norway
Norwegian Air Ambulance Foundation
Information provided by:
University of Oslo
ClinicalTrials.gov Identifier:
NCT00121524
First received: July 13, 2005
Last updated: June 11, 2008
Last verified: June 2008
  Purpose

Intravenous epinephrine has been part of the guidelines for cardiopulmonary resuscitation since the start. It improves outcome in animal studies, but has never been investigated in a controlled study in humans. Epidemiologic data indicate that it is an independent negative predictor for survival. If this is true in a controlled randomized study, it could be due to effects of the drug itself or more likely due to reduced quality of chest compressions and ventilations due to the time spent on placing an I.V. needle and injecting drugs.


Condition Intervention Phase
Cardiac Arrest
Drug: epinephrine and intravenous needle
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Epinephrine and I.V. Needle on CPR Outcome

Resource links provided by NLM:


Further study details as provided by University of Oslo:

Primary Outcome Measures:
  • survival to hospital discharge with neurologic outcome [ Time Frame: discharge from hospital ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • admit to hospital with spontaneous circulation [ Time Frame: hospital admission ] [ Designated as safety issue: No ]
  • one year survival with neurologic outcome [ Time Frame: one year after hospital discharge ] [ Designated as safety issue: Yes ]

Enrollment: 904
Study Start Date: January 2003
Study Completion Date: June 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: IV yes
ACLS with an iv needle and the use of drugs during CPR
Drug: epinephrine and intravenous needle
epinephrine 1 mg iv. q 3 min during CPR, atropin 3 mg iv in initial asystole, amiodarone 300 mg iv after repeated failed defibrillation attempts
Other Names:
  • Adrenalin
  • Atropin
  • Cordarone
No Intervention: IV no
No IV needle or drugs given during CPR
Drug: epinephrine and intravenous needle
epinephrine 1 mg iv. q 3 min during CPR, atropin 3 mg iv in initial asystole, amiodarone 300 mg iv after repeated failed defibrillation attempts
Other Names:
  • Adrenalin
  • Atropin
  • Cordarone

Detailed Description:

In a randomized, controlled study of all out-of-hospital cardiac arrest patients in Oslo, Norway, half the patients are treated according to the international guidelines for advanced CPR, and the other half according to the same guidelines, except for no I.V. needle or drugs are given until 5 minutes after eventual return of spontaneous circulation.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Cardiac arrest out-of-hospital

Exclusion Criteria:

  • <18 years old
  • Trauma as cause of arrest
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00121524

Locations
Norway
Ulleval University Hospital
Oslo, Norway, N-0407
Sponsors and Collaborators
University of Oslo
Laerdal Medical
Ullevaal University Hospital
Health Region East, Norway
Norwegian Air Ambulance Foundation
Investigators
Principal Investigator: Lars Wik, MD, PhD Ullevaal University Hospital
  More Information

Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Petter Andreas Steen/professor, University of Oslo and Ulleval University Hospital
ClinicalTrials.gov Identifier: NCT00121524     History of Changes
Other Study ID Numbers: 525-02201
Study First Received: July 13, 2005
Last Updated: June 11, 2008
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Keywords provided by University of Oslo:
cardiac arrest
resuscitation
epinephrine
intravenous
survival

Additional relevant MeSH terms:
Heart Arrest
Heart Diseases
Cardiovascular Diseases
Epinephrine
Epinephryl borate
Adrenergic beta-Agonists
Adrenergic Agonists
Adrenergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Bronchodilator Agents
Autonomic Agents
Peripheral Nervous System Agents
Anti-Asthmatic Agents
Respiratory System Agents
Therapeutic Uses
Mydriatics
Adrenergic alpha-Agonists
Sympathomimetics
Vasoconstrictor Agents
Cardiovascular Agents

ClinicalTrials.gov processed this record on July 22, 2014